[Relapse of acute promyelocytic leukemia in the central nervous system revealed by isolated dementia]

Rev Med Interne. 2016 Dec;37(12):844-848. doi: 10.1016/j.revmed.2016.02.015. Epub 2016 Mar 25.
[Article in French]

Abstract

Introduction: Approximately 1.5% of dementia is due to curable aetiology. We report an isolated dementia syndrome due to a meningeal relapse of acute promyelocytic leukaemia with favourable outcome after appropriate treatment.

Case report: A 72-year-old woman, in remission of an acute promyelocytic leukaemia, presented a loss of autonomy for several months due to corticosubcortical dementia. Lumbar puncture showed blast cells indicating meningeal relapse of leukaemia. Intrathecal chemotherapy and arsenic trioxide obtained biological and molecular remission as well as restoration of normal cognitive functions.

Conclusion: In patients with hematologic past history such as acute promyelocytic leukaemia, an isolated cognitive impairment should alert physicians to search for an isolated neuromeningeal relapse.

Keywords: Acute promyelocytic leukaemia; Central nervous system; Dementia; Démence; Leucémie aiguë promyélocytaire; Rechute; Relapse; Système nerveux central.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Arsenic Trioxide
  • Arsenicals / therapeutic use*
  • Dementia / diagnosis*
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute / diagnosis*
  • Leukemia, Promyelocytic, Acute / drug therapy
  • Meningeal Neoplasms / diagnosis*
  • Meningeal Neoplasms / drug therapy
  • Neoplasm Recurrence, Local / diagnosis*
  • Oxides / therapeutic use*
  • Recurrence
  • Remission Induction

Substances

  • Arsenicals
  • Oxides
  • Arsenic Trioxide